Nifedipine in the Treatment of Hypertension in the Elderly
- 1 April 1985
- journal article
- research article
- Published by Wiley in The Journal of Clinical Pharmacology
- Vol. 25 (3), 193-196
- https://doi.org/10.1002/j.1552-4604.1985.tb02824.x
Abstract
The effect of nifedipine monotherapy, retard tablets, 20 mg bid, was evaluated in 23 hypertensive patients, mean age, 79 ± 2 years. Twenty‐one patients completed an eight‐week study. Blood pressure (BP) decreased to 160/90 mm Hg in 15 patients; in four additional patients diastolic BP dropped by 15% to 28%. In a subset of five patients with isolated systolic hypertension, a significant reduction in systolic BP was noted. Side effects were relatively mild and only two patients discontinued the study. The results suggest that nifedipine monotherapy offers an alternative, logic, therapeutic approach to hypertension in the elderly.This publication has 7 references indexed in Scilit:
- Factors influencing the hypotensive effects of calcium antagonists.Hypertension, 1983
- Pharmacokinetic studies of nifedipine tablet. Correlation with antihypertensive effects.Hypertension, 1983
- Effectiveness of combined nifedipine and propranolol treatment in hypertension.Hypertension, 1983
- Treatment of mild hypertension in the elderly: A study initiated and administered by the National Heart Foundation of AustraliaThe Medical Journal of Australia, 1981
- Antihypertensive treatment in the elderly.BMJ, 1979
- Five-Year Findings of the Hypertension Detection and Follow-up ProgramJAMA, 1979
- Antihypertensive Therapy in Patients above Age 60 Years (Fourth Interim Report of the European Working Party on High Blood Pressure in Elderly: EWPHE)Clinical Science, 1978